Hamel Associates, Inc. Becton Dickinson & CO Transaction History

Hamel Associates, Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 04, 2021	SELL	$232.65 - $254.58 $210,548 - $230,394	-905 Closed	0 $0
Q1 2021 May 04, 2021	SELL	$232.09 - $256.88 $63,824 - $70,642	-275 Reduced 23.31%	905 $220,000
Q4 2019 Feb 12, 2020	SELL	$236.45 - $266.82 $88,668 - $100,057	-375 Reduced 24.12%	1,180 $321,000
Q3 2019 Nov 12, 2019	SELL	$230.58 - $256.08 $17,293 - $19,206	-75 Reduced 4.6%	1,555 $393,000
Q2 2019 Aug 05, 2019	SELL	$217.4 - $246.08 $10,870 - $12,304	-50 Reduced 2.98%	1,630 $411,000
Q1 2019 May 01, 2019	SELL	$206.05 - $248.17 $113,327 - $136,493	-550 Reduced 24.66%	1,680 $420,000
Q3 2018 Oct 25, 2018	SELL	$233.07 - $256.0 $23,307 - $25,600	-100 Reduced 4.29%	2,230 $582,000
Q2 2018 Aug 10, 2018	SELL	$208.1 - $233.85 $26,012 - $29,231	-125 Reduced 5.09%	2,330 $558,000
Q1 2018 May 03, 2018	SELL	$205.46 - $240.27 $102,730 - $120,135	-500 Reduced 16.92%	2,455 $532,000
Q2 2017 Aug 11, 2017	BUY	N/A	2,955	2,955 $577,000

1,735

250M

690K

787K

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $64.2B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

Get notified when there are updates to the investment portfolio of Hamel Associates, Inc., based on Form 13F filings with the SEC.

Stay updated on Hamel Associates, Inc. with notifications on news.